chartexchange

Gain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update

GlobeNewswire Inc. | Nov 10, 2026 7:00 AM EST

BETHESDA, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reported financial results for the quarter ended September 30, 2026, and provided a corporate update.

Read original article